A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Abemaciclib

Abemaciclib & 其杂质

Abemaciclib is a medication for the treatment of advanced or metastatic breast cancers. Abemaciclib is an antitumor agent and dual inhibitor of cyclin-dependent kinases 4 (CDK4) and 6 (CDK6) that are involved in the cell cycle and promotion of cancer cell growth in case of unregulated activity. It was designated as a breakthrough therapy for breast cancer by the US Food and Drug Administration (FDA).

SynZeal 是药用对照品领域的领先创新者。我们提供高质量的对照品 Abemaciclib，药典及非药典 Abemaciclib 杂质、代谢物、稳定同位素产品以及亚硝胺（N-NO 产品）。 Abemaciclib 杂质对照品在药物研发中非常有用。它们在产品开发、ANDA 和 DMF 申报、质量控制（QC）、方法验证及稳定性研究中均有应用。同时，它们也用于未知杂质的识别及基因毒性潜力的评估。